115 related articles for article (PubMed ID: 27478175)
1. In Silico Models to Discriminate Compounds Inducing and Noninducing Toxic Myopathy.
Hu X; Yan A
Mol Inform; 2012 Jan; 31(1):27-39. PubMed ID: 27478175
[TBL] [Abstract][Full Text] [Related]
2. In silico prediction of rhabdomyolysis of compounds by self-organizing map and support vector machine.
Hu X; Yan A
Toxicol In Vitro; 2011 Dec; 25(8):2017-24. PubMed ID: 21856410
[TBL] [Abstract][Full Text] [Related]
3. Classification of Aurora-A Kinase Inhibitors Using Self-Organizing Map (SOM) and Support Vector Machine (SVM).
Wang L; Wang Z; Yan A; Yuan Q
Mol Inform; 2011 Jan; 30(1):35-44. PubMed ID: 27467876
[TBL] [Abstract][Full Text] [Related]
4. Classification of Aurora kinase inhibitors by self-organizing map (SOM) and support vector machine (SVM).
Yan A; Nie X; Wang K; Wang M
Eur J Med Chem; 2013 Mar; 61():73-83. PubMed ID: 22796044
[TBL] [Abstract][Full Text] [Related]
5. Discrimination of Active and Weakly Active Human BACE1 Inhibitors Using Self-Organizing Map and Support Vector Machine.
Li H; Wang M; Gong YN; Yan A
Comb Chem High Throughput Screen; 2016; 19(6):470-80. PubMed ID: 27141991
[TBL] [Abstract][Full Text] [Related]
6. Self-Organizing Map (SOM) and Support Vector Machine (SVM) Models for the Prediction of Human Epidermal Growth Factor Receptor (EGFR/ ErbB-1) Inhibitors.
Kong Y; Qu D; Chen X; Gong YN; Yan A
Comb Chem High Throughput Screen; 2016; 19(5):400-11. PubMed ID: 27074760
[TBL] [Abstract][Full Text] [Related]
7. Using self-organizing map (SOM) and support vector machine (SVM) for classification of selectivity of ACAT inhibitors.
Wang L; Wang M; Yan A; Dai B
Mol Divers; 2013 Feb; 17(1):85-96. PubMed ID: 23124952
[TBL] [Abstract][Full Text] [Related]
8. In-silico prediction of blood-brain barrier permeability.
Yan A; Liang H; Chong Y; Nie X; Yu C
SAR QSAR Environ Res; 2013 Jan; 24(1):61-74. PubMed ID: 23092117
[TBL] [Abstract][Full Text] [Related]
9. Computational models for the classification of mPGES-1 inhibitors with fingerprint descriptors.
Xia Z; Yan A
Mol Divers; 2017 Aug; 21(3):661-675. PubMed ID: 28484935
[TBL] [Abstract][Full Text] [Related]
10. Prediction of human intestinal absorption by GA feature selection and support vector machine regression.
Yan A; Wang Z; Cai Z
Int J Mol Sci; 2008 Oct; 9(10):1961-76. PubMed ID: 19325729
[TBL] [Abstract][Full Text] [Related]
11. SAR study on inhibitors of GIIA secreted phospholipase A
Zhang S; Li Y; Qin Z; Tu G; Chen G; Yan A
Chem Biol Drug Des; 2019 May; 93(5):666-684. PubMed ID: 30582300
[TBL] [Abstract][Full Text] [Related]
12. Prediction of bioactivity of HIV-1 integrase ST inhibitors by multilinear regression analysis and support vector machine.
Xuan S; Wu Y; Chen X; Liu J; Yan A
Bioorg Med Chem Lett; 2013 Mar; 23(6):1648-55. PubMed ID: 23395655
[TBL] [Abstract][Full Text] [Related]
13. Discriminating of ATP competitive Src kinase inhibitors and decoys using self-organizing map and support vector machine.
Yan A; Hu X; Wang K; Sun J
Mol Divers; 2013 Feb; 17(1):75-83. PubMed ID: 23117252
[TBL] [Abstract][Full Text] [Related]
14. SAR and QSAR models of cyclooxygenase-1 (COX-1) inhibitors.
Xi Y; Qin Z; Yan A
SAR QSAR Environ Res; 2018 Oct; 29(10):755-784. PubMed ID: 30274533
[TBL] [Abstract][Full Text] [Related]
15. Computational models on quantitative prediction of bioactivity of HIV-1 integrase 3' processing inhibitors.
Kong Y; Xuan S; Yan A
SAR QSAR Environ Res; 2014; 25(9):729-46. PubMed ID: 25121566
[TBL] [Abstract][Full Text] [Related]
16. Prediction of biological activity of Aurora-A kinase inhibitors by multilinear regression analysis and support vector machine.
Yan A; Chong Y; Wang L; Hu X; Wang K
Bioorg Med Chem Lett; 2011 Apr; 21(8):2238-43. PubMed ID: 21421314
[TBL] [Abstract][Full Text] [Related]
17. SAR and QSAR study on the bioactivities of human epidermal growth factor receptor-2 (HER2) inhibitors.
Qu D; Yan A; Zhang JS
SAR QSAR Environ Res; 2017 Feb; 28(2):111-132. PubMed ID: 28235391
[TBL] [Abstract][Full Text] [Related]
18. Classification of Aurora B kinase inhibitors using computational models.
Liu R; Nie X; Zhong M; Hou X; Xuan S; Yan A
Comb Chem High Throughput Screen; 2014 Feb; 17(2):114-23. PubMed ID: 24152178
[TBL] [Abstract][Full Text] [Related]
19. Prediction of chemical carcinogenicity by machine learning approaches.
Tan NX; Rao HB; Li ZR; Li XY
SAR QSAR Environ Res; 2009; 20(1-2):27-75. PubMed ID: 19343583
[TBL] [Abstract][Full Text] [Related]
20. In silico prediction of major drug clearance pathways by support vector machines with feature-selected descriptors.
Toshimoto K; Wakayama N; Kusama M; Maeda K; Sugiyama Y; Akiyama Y
Drug Metab Dispos; 2014 Nov; 42(11):1811-9. PubMed ID: 25128502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
